brimonidine tartrate has been researched along with Macular Degeneration in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Díaz Barrón, A; Duch Samper, AM; Gil-Hernández, I; López Montero, A; Vidal Oliver, L | 1 |
| Augustin, AJ; Boyer, DS; Freeman, WR; Guo, Q; Kerr, KJ; Kuppermann, BD; López, FJ; Patel, SS; Schneider, S | 1 |
| Brent, MH; Felfeli, T; Hostovsky, A; Mandelcorn, ED; Trussart, R; Yan, P | 1 |
| Saumur, M; Weng, CY | 1 |
| Arriola-Villalobos, P; Benítez-del-Castillo, JM; Díaz-Valle, D; García-Catalán, MR; García-Sánchez, J; Gil-de-Bernabé, J; Santos-Bueso, E | 1 |
| Dot, C; El Chehab, H; Giraud, JM; Le Corre, A; Ract-Madoux, G; Swalduz, B | 1 |
3 trial(s) available for brimonidine tartrate and Macular Degeneration
| Article | Year |
|---|---|
PHASE 2 STUDY OF THE SAFETY AND EFFICACY OF BRIMONIDINE DRUG DELIVERY SYSTEM (BRIMO DDS) GENERATION 1 IN PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Aged, 80 and over; Brimonidine Tartrate; Double-Blind Method; Drug Delivery Systems; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Geographic Atrophy; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Treatment Outcome; Visual Acuity | 2021 |
Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial.
Topics: Administration, Ophthalmic; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antihypertensive Agents; Bevacizumab; Brimonidine Tartrate; Cross-Over Studies; Double-Blind Method; Female; Humans; Intraocular Pressure; Intravitreal Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Ranibizumab; Retinal Vein Occlusion; Tonometry, Ocular; Treatment Outcome | 2019 |
[Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
Topics: Acetazolamide; Aged; Antibodies, Monoclonal, Humanized; Antihypertensive Agents; Bevacizumab; Brimonidine Tartrate; Chemoprevention; Clonidine; Drug Combinations; Female; Humans; Hypotonic Solutions; Intraocular Pressure; Intravitreal Injections; Macular Degeneration; Male; Ocular Hypertension; Quinoxalines; Sulfonamides; Thiophenes; Timolol; Tonometry, Ocular; Treatment Outcome | 2012 |
3 other study(ies) available for brimonidine tartrate and Macular Degeneration
| Article | Year |
|---|---|
A Case of Sterile Corneal Stromal Infiltration with Hypotonic Maculopathy Under Brimonidine Treatment.
Topics: Aged; Brimonidine Tartrate; Conjunctivitis; Cornea; Humans; Intraocular Pressure; Macular Degeneration; Male; Ocular Hypertension; Ophthalmic Solutions; Retinal Diseases | 2023 |
Upcoming Therapies for Age-related Macular Degeneration.
Topics: Adrenergic alpha-2 Receptor Agonists; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Brimonidine Tartrate; Complement Inactivating Agents; Genetic Therapy; Humans; Macular Degeneration; Protein Kinase Inhibitors; Vascular Endothelial Growth Factor A | 2019 |
[Charles Bonnet syndrome precipitated by brimonidine].
Topics: Administration, Ophthalmic; Adrenergic alpha-2 Receptor Agonists; Aged, 80 and over; Brimonidine Tartrate; Exfoliation Syndrome; Female; Hallucinations; Humans; Macular Degeneration; Neurologic Examination; Occipital Lobe; Postoperative Complications; Quinoxalines; Sulfonamides; Thiazines; Trabeculectomy; Visual Acuity | 2013 |